-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate total amount of expenses directly related to the marketing or selling of products or services.
-
Summary
-
LexaGene Holdings Inc. quarterly Selling and Marketing Expense history and growth rate from Q3 2021 to Q4 2022.
- LexaGene Holdings Inc. Selling and Marketing Expense for the quarter ending November 30, 2022 was $167K, a 69.4% decline year-over-year.
Selling and Marketing Expense, Quarterly (USD)
Selling and Marketing Expense, YoY Quarterly Growth (%)